The Valens Company Enters Topicals Category with Launch of nūance CBD Bath Bombs
nūance CBD bath bombs are now available in Ontario and British Columbia and expected to be coming soon to Alberta
Kelowna, B.C., April 14, 2021 – The Valens Company Inc. (TSX: VLNS) (OTCQX: VLNCF) (the “Company” or “The Valens Company”), a leading manufacturer of cannabis products, today announced the launch of nūance CBD bath bombs. The bath bombs will join nūance’s lineup of premium wellness products developed with trusted ingredients and designed to provide consumers customizable self-care experiences.
Each nūance bath bomb is crafted with all-natural plant-derived essential oils and infused with 100mg of premium CBD. Designed for ready-to-use self-care at home, consumers can simply drop the CBD bath bomb in warm bathwater, relax and take in the aromatic scents. Currently the largest bath bombs available in the Canadian recreational market with two minutes of fizz, the products are offered in two formats, including:
- Soothing Eucalyptus, infused with eucalyptus essential oil to refresh the senses, now available in Ontario and British Columbia and expected to be coming soon to Alberta
- Revitalizing Grapefruit, infused with Citrus Paradisi peel essential oil to awaken the senses, now available in British Columbia and expected to be coming soon to Alberta
“We are thrilled to introduce nūance bath bombs to the market when now more than ever we are all looking for new and innovative ways to indulge in at-home self-care,” said Tyler Robson, CEO, Co-Founder and Chair of The Valens Company. “These products represent the first Valens-manufactured topicals in the market, created with the same commitment to excellence and quality as our other leading products in various next generation categories. We look forward to introducing a variety of innovative and highly customizable products exclusive to the wellness category, in collaboration with our partners over the course of 2021.”
Additional nūance wellness products are expected to launch in the coming quarters, including balm, menthol rub, soft chews, and honey. This also includes a new variety of bath bombs, such as the 1:1 CBD/THC artisanal mini bath bomb four-pack pairing of two classic complementary scents, which can be used individually or in combination for a highly customizable user experience.
At Valens, it’s Personal.
About The Valens Company
The Valens Company is a leading manufacturer of cannabis products with a mission to bring the benefits of cannabis to the world. The Company provides proprietary cannabis processing services across five core technologies, in addition to best-in-class product development, formulation and manufacturing of cannabis consumer packaged goods. The Valens Company’s high-quality products are exclusively formulated for the medical, therapeutic, health and wellness, and recreational consumer segments, and are offered across numerous product formats, including oils, vapes, concentrates, edibles and topicals, as well as pre-rolls, with a focus on next-generation product development and innovation. Its breakthrough patented emulsification technology, SōRSE™ by Valens, converts cannabis oil into water-soluble emulsions for seamless integration into a variety of product formats, allowing for near-perfect dosing, stability, and taste. In partnership with brand houses, consumer packaged goods companies and licensed cannabis producers around the globe, the Company continues to grow its diverse product portfolio in alignment with evolving cannabis consumer preferences in key markets. Through its wholly owned subsidiary Valens Labs Ltd., the Company is setting the standard in cannabis testing and research and development with Canada’s only ISO17025 accredited analytical services lab, named The Centre of Excellence in Plant-Based Science by partner and scientific world leader Thermo Fisher Scientific. Discover more on The Valens Company and its subsidiaries at https://thevalenscompany.com.
For further information, please contact:
The Valens Company
KCSA Strategic Communications
Phil Carlson / Elizabeth Barker
1 212.896.1233 / 1 212.896.1203
KCSA Strategic Communications
Notice regarding Forward Looking Statements
All information included in this press release, including any information as to the future financial or operating performance and other statements of The Valens Company that express management’s expectations or estimates of future performance, other than statements of historical fact, constitute forward-looking information or forward-looking statements within the meaning of applicable securities laws and are based on expectations, estimates and projections as of the date hereof. Forward-looking statements are included for the purpose of providing information about management’s current expectations and plans relating to the future. Wherever possible, words such as “plans”, “expects”, “scheduled”, “trends”, “indications”, “potential”, “estimates”, “predicts”, “anticipate”, “to establish”, “believe”, “intend”, “ability to”, or statements that certain actions, events or results “may”, “could”, “would”, “might”, “will”, or are “likely” to be taken, occur or be achieved, or the negative of these words or other variations thereof, have been used to identify such forward-looking information. Specific forward-looking statements include, without limitation, all disclosure regarding future results of operations, economic conditions and anticipated courses of action.
The risks and uncertainties that may affect forward-looking statements include, among others, regulatory risk, United States border crossing and travel bans, reliance on licenses, expansion of facilities, competition, dependence on supply of cannabis and reliance on other key inputs, dependence on senior management and key personnel, general business risk and liability, regulation of the cannabis industry, change in laws, regulations and guidelines, compliance with laws, reliance on a single facility, limited operating history, vulnerability to rising energy costs, unfavourable publicity or consumer perception, product liability, risks related to intellectual property, product recalls, difficulties with forecasts, management of growth and litigation, many of which are beyond the control of The Valens Company. For a more comprehensive discussion of the risks faced by The Valens Company, and which may cause the actual financial results, performance or achievements of The Valens Company to be materially different from estimated future results, performance or achievements expressed or implied by forward-looking information or forward-looking statements, please refer to The Valens Company’s latest Annual Information Form filed with Canadian securities regulatory authorities at www.sedar.com or on The Valens Company’s website at www.thevalenscompany.com. The risks described in such Annual Information Form are hereby incorporated by reference herein. Although the forward-looking statements contained herein reflect management’s current beliefs and reasonable assumptions based upon information available to management as of the date hereof, The Valens Company cannot be certain that actual results will be consistent with such forward-looking information. The Valens Company cautions you not to place undue reliance upon any such forward-looking statements. The Valens Company disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law. Nothing herein should be construed as either an offer to sell or a solicitation to buy or sell securities of The Valens Company.